MindWalk Holdings Stock (NASDAQ:HYFT)


RevenueFinancialsChartTranscripts

Previous Close

$1.64

52W Range

$0.27 - $3.25

50D Avg

$1.98

200D Avg

$1.09

Market Cap

$79.85M

Avg Vol (3M)

$1.36M

Beta

0.69

Div Yield

-

HYFT Company Profile


MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

81

IPO Date

Jan 07, 2002

Website

HYFT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceApr 25Apr 24Apr 23
Project Revenue$22.18M$22.23M$18.68M
Product Sales$2.11M$2.04M$1.75M

Fiscal year ends in Apr 25 | Currency in CAD

HYFT Financial Summary


Apr 25Apr 24Apr 23
Revenue$24.52M$24.52M$20.66M
Operating Income$-12.20M$-13.76M$-25.61M
Net Income$-30.23M$-27.18M$-26.56M
EBITDA$-28.86M$-22.95M$-21.04M
Basic EPS$-0.91$-1.06$-1.07
Diluted EPS$-0.91$-1.06$-1.07

Fiscal year ends in Apr 25 | Currency in CAD

Latest Earnings Call Transcripts


Q1 26Sep 15, 25 | 11:30 AM
Q4 25Jul 29, 25 | 10:30 AM
Q3 25Mar 28, 25 | 10:30 AM

Peer Comparison


TickerCompany
IMAImageneBio Inc
LITSLite Strategy, Inc.
CRVOCervoMed Inc.
IFRXInflaRx N.V.
RPTXRepare Therapeutics Inc.
FBIOFortress Biotech, Inc.
NTRBNutriband Inc.
XBITXBiotech Inc.
IMUXImmunic, Inc.
UNCYUnicycive Therapeutics, Inc.